The clinical utility of LB has been demonstrated for the detection of epidermal growth factor receptor (EGFR) mutations in NSCLC patients or for the detection of KRAS proto-oncogene, GTPase (KRAS) mutations in patients suffering from metastatic CRC [24]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.